VT
IONS icon

Vise Technologies’s Ionis Pharmaceuticals IONS Stock Holding History

Vise Technologies’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$341K Hold
4,305
– – 0.01% 1078
2025
Q4 		$341K Buy
+4,305
New +$324K 0.01% 1084

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vise Technologies's IONS Position: Q1 2026 in Review

Vise Technologies held its Ionis Pharmaceuticals (IONS) position steady in Q1 2026 at 4,305 shares worth $341K. The position accounts for 0.01% of the portfolio, ranked #1078.

Vise Technologies first reported a position in IONS in Q4 2025 and has held it in 2 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Vise Technologies held 4,305 shares of Ionis Pharmaceuticals worth $341K as of Q1 2026.
  • Vise Technologies left its Ionis Pharmaceuticals share count unchanged in Q1 2026.
  • Ionis Pharmaceuticals made up 0.01% of Vise Technologies's portfolio in Q1 2026, its #1078 holding.
  • Vise Technologies first reported a position in Ionis Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Vise Technologies's 13F filing for Q1 2026, filed 21 Apr 2026.